Steady-state concentration of fentanyl with the Matrifen® patch

The steady-state concentration of fentanyl in the Matrifen® transdermal patch from Nycomed helps to relieve the severe chronic pain, such as cancer pain and low back pain.

Matrifen® has a steady-state concentration of fentanyl wich provides strong relief for all chronic pain. 

>> Information on steady-state concentration of fentanyl

The 72 hour transdermal fentanyl patch Matrifen provides a steady state concentration of fentanyl to ease pain in patients with severe chronic pain.

The fentanyl drug load is less than in other products, adding to a high degree of safety and low environmental burden.

Fentanyl belongs to the group of opioids, and transdermal fentanyl has been shown to have fewer side effects compared to morphine tablets and other oral formulations of opiod analgesics.

About Nycomed
Nycomed is a young company with a long history. Founded in 1874 in Norway by Morten Nyegaard, the company gradually began to expand into Europe, forming a strong position initially in the Nordic countries.

The modern story really begins in 1999, when Nycomed was established as a European company with a focus on sourcing and developing new pharmaceutical products. With this in place, the pace of this market expansion increased and the company now operates throughout Europe.

Nociceptive pain | Opioid tolerance | 72 hour patch